Page last updated: 2024-10-22

tyrphostin ag 1024 and Acute Lymphoid Leukemia

tyrphostin ag 1024 has been researched along with Acute Lymphoid Leukemia in 1 studies

tyrphostin AG 1024: modulates radiosensitivity in human breast cancer cells; also an IGF1 receptor inhibitor

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Weston, VJ1
Wei, W1
Stankovic, T1
Kearns, P1

Other Studies

1 other study available for tyrphostin ag 1024 and Acute Lymphoid Leukemia

ArticleYear
Synergistic action of dual IGF1/R and MEK inhibition sensitizes childhood acute lymphoblastic leukemia (ALL) cells to cytotoxic agents and involves downregulation of STAT6 and PDAP1.
    Experimental hematology, 2018, Volume: 63

    Topics: Butadienes; Cell Cycle; Chromones; Daunorubicin; Down-Regulation; Drug Synergism; Gene Expression Pr

2018